Journal
Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and neurodisability for over 60 years, and is one of the world’s leading journals in the whole field of paediatrics. Owned by Mac Keith Press, DMCN is of interest to researchers, all health professionals concerned with developmental disability and child neurology, and others involved with the care of children and young people. The high quality of published articles is maintained by expert review, including independent statistical assessment, before acceptance.
DMCN has a wide international authorship and readership, and is available in thousands of libraries around the world. It is also available as part of membership of selected societies and organisations. DMCN will accept advertising that accords with its editorial policies.
2-Year Impact Factor: 3.8
5-Year Impact Factor: 4.7
Submission to first decision: 7 days
Acceptance to online publication: 41 days
Acceptance rate: 31%
Updated Description of Cerebral Palsy
Editor’s Choice
Translated Material
Here we compile Developmental Medicine & Child Neurology content that has been translated into languages other than English.
Read moreAbout DMCN
DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.
Read moreEditorial Services
DMCN Podcasts
Enjoyed reading DMCN? Listen to our range of DMCN Podcasts on YouTube and Apple Podcasts featuring interviews and discussions with authors and editors.
Virtual Issues
Read our recent Virtual Issues here.
Plain Language Summaries
Peer Review
Here we present useful resources for peer reviewers including tips for reviewing, AI in peer review, recognition for reviewers and more.
Read moreLetters to the Editor